Gastrointestinal%20Stromal%20Tumors
Showing 9976 - 10000 of >10,000
Head and Neck Squamous Cell Carcinoma Trial in United States (afatinib, )
Terminated
- Head and Neck Squamous Cell Carcinoma
- afatinib
- placebo
-
Anchorage, Alaska
- +271 more
Jan 11, 2021
Urothelial Cancer Trial in Australia, Canada (Nab-Paclitaxel, Paclitaxel)
Completed
- Urothelial Cancer
-
Douglas, Queensland, Australia
- +36 more
Oct 28, 2020
Nasopharyngeal Carcinoma Trial in Guangzhou (Cisplatin+Toripalimab, Cisplatin+)
Recruiting
- Nasopharyngeal Carcinoma
- Cisplatin+Toripalimab
- Cisplatin+placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen Universitty Cancer Center
Apr 20, 2020
Lymphoma Trial in Houston (Fludarabine, Novantrone, Decadron)
Completed
- Lymphoma
- Fludarabine
- +14 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 22, 2020
Prostate Cancer in African-American and Caucasian Males
Completed
- Prostate Cancer
-
Baltimore, Maryland
- +1 more
Aug 13, 2020
Renal Transplantation, Gastrointestinal Problems Trial in Bonn, Basel (Enteric-Coated Mycophenolate Sodium (EC-MPS))
Completed
- Renal Transplantation
- Gastrointestinal Problems
- Enteric-Coated Mycophenolate Sodium (EC-MPS)
-
Bonn, Germany
- +1 more
Feb 8, 2020
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States
Completed
- Anaplastic Astrocytoma
- +3 more
- 3-Dimensional Conformal Radiation Therapy
- +3 more
-
Birmingham, Alabama
- +179 more
Oct 5, 2021
Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)
Prostate Cancer Trial in Houston (Selinexor)
Terminated
- Prostate Cancer
-
Houston, TexasM.D. Anderson Cancer Center
Jan 7, 2021
Brain Tumors, Adult, Malignant Trial in Dallas (Radiotherapy)
Completed
- Brain Neoplasms, Adult, Malignant
- Radiotherapy
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Jan 5, 2021
Melanoma, Kidney Cancer Trial in St. Petersburg (Tag-7 gene modified inactivated tumor cells)
Completed
- Melanoma
- Kidney Cancer
- Tag-7 gene modified inactivated tumor cells
-
St. Petersburg, Russian FederationN.N. Petrov Research Institute of Oncology Chemotherapy and Inno
Dec 3, 2019
Brain Tumors Trial in Durham, Memphis, Houston (Induction therapy (Regimen 1, Course 1, Cycle A1, Regimen 1, Course 1, Cycle A2
Completed
- Brain Tumors
- Induction therapy (Regimen 1, Course 1, Cycle A1
- +9 more
-
Durham, North Carolina
- +2 more
Mar 2, 2020
Basal Cell Nevus Syndrome Trial in London, Manchester (Patidegib, Vehicle gel)
Completed
- Basal Cell Nevus Syndrome
- Patidegib
- Vehicle gel
-
London, United Kingdom
- +1 more
Jul 8, 2020
Gastrointestinal Stromal Tumors Trial in Worldwide (Dovitinib (TKI258))
Completed
- Gastrointestinal Stromal Tumors
- Dovitinib (TKI258)
-
HUS, Finland
- +14 more
Apr 26, 2016
Lymphoma Trial in Houston (Cyclophosphamide, Mesna, Vincristine)
Completed
- Lymphoma
- Cyclophosphamide
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 2, 2020
Chronic Wounds Trial in Indiana (Antria Cell Preparation Process)
Recruiting
- Chronic Wounds
- Antria Cell Preparation Process
-
Indiana, PennsylvaniaIndiana Regional Medical Center
Mar 18, 2019
Colorectal Cancer Trial in Petach Tiqva (Capecitabine, Cyclophosphamide, Methotrexate)
Completed
- Colorectal Cancer
- Capecitabine
- +3 more
-
Petach Tiqva, IsraelGastrointestinal Oncology Unit, Institute of Oncology, Davidoff
Feb 11, 2020
Breast Cancer, Metastases Trial in Worldwide (Ixabepilone + Capecitabine, Capecitabine)
Completed
- Breast Cancer
- Metastases
- Ixabepilone + Capecitabine
- Capecitabine
-
Little Rock, Arkansas
- +126 more
Oct 6, 2020
Malignant Tumor Trial in Shenzhen (Decitabine, DC-CIK)
Unknown status
- Malignant Neoplasm
- Decitabine
- DC-CIK
-
Shenzhen, ChinaShenzhen university general hospital
Feb 28, 2020
HER2/Neu Negative, Recurrent Inflammatory Breast Carcinoma, Stage IV Breast Cancer Trial in Chicago (Ipilimumab, Laboratory
Terminated
- HER2/Neu Negative
- +3 more
- Ipilimumab
- +2 more
-
Chicago, IllinoisNorthwestern University
Jun 30, 2020